(ENI) Eni S.p.A. - Overview
Stock: Oil, Natural Gas, Refined Fuels, Chemicals, Renewables
| Risk 5d forecast | |
|---|---|
| Volatility | 26.0% |
| Relative Tail Risk | 2.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.65 |
| Alpha | 68.70 |
| Character TTM | |
|---|---|
| Beta | 0.352 |
| Beta Downside | 0.700 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.50% |
| CAGR/Max DD | 1.31 |
EPS (Earnings per Share)
Revenue
Description: ENI Eni S.p.A. March 05, 2026
Eni S.p.A. is an integrated energy company with global operations spanning exploration, production, refining, and marketing of oil, natural gas, and related products. The companys business model encompasses the entire energy value chain, from upstream resource extraction to downstream product distribution. Integrated oil and gas companies typically manage diverse assets to mitigate commodity price volatility.
Eni also emphasizes renewable energy and sustainable mobility solutions. This includes power generation from renewable sources, biofuel production, and electric vehicle charging infrastructure. The energy sector is undergoing a transition towards decarbonization, with many integrated companies diversifying into cleaner energy technologies.
Enis operations are segmented, including Exploration & Production, Global Gas & LNG Portfolio and Power, Refining and Chemicals, Enilive, and Plenitude. This structure allows for specialized management of distinct business areas. To delve deeper into Enis financial performance and strategic initiatives, further research on ValueRay could be beneficial.
Headlines to watch out for
- Global crude oil and natural gas prices dictate exploration and production revenue
- Regulatory shifts in EU energy policy impact renewable investments
- Downstream refining margins influenced by product demand and input costs
- Geopolitical instability in producing regions threatens supply and operations
- Expansion of renewable energy portfolio diversifies revenue streams
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 4.44b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.70 > 1.0 |
| NWC/Revenue: 4.35% < 20% (prev 9.77%; Δ -5.42% < -1%) |
| CFO/TA 0.15 > 3% & CFO 20.89b > Net Income 4.44b |
| Net Debt (20.23b) to EBITDA (15.97b): 1.27 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.00b) vs 12m ago -4.58% < -2% |
| Gross Margin: 32.24% > 18% (prev 0.12%; Δ 3.21k% > 0.5%) |
| Asset Turnover: 93.49% > 50% (prev 64.53%; Δ 28.96% > 0%) |
| Interest Coverage Ratio: 1.13 > 6 (EBITDA TTM 15.97b / Interest Expense TTM 7.56b) |
Altman Z'' 2.39
| A: 0.04 (Total Current Assets 39.48b - Total Current Liabilities 33.91b) / Total Assets 134.99b |
| B: 0.34 (Retained Earnings 45.25b / Total Assets 134.99b) |
| C: 0.06 (EBIT TTM 8.56b / Avg Total Assets 137.17b) |
| D: 0.57 (Book Value of Equity 49.25b / Total Liabilities 85.74b) |
| Altman-Z'' Score: 2.39 = BBB |
Beneish M -3.67
| DSRI: 0.64 (Receivables 12.41b/13.55b, Revenue 128.25b/89.93b) |
| GMI: 0.39 (GM 32.24% / 12.42%) |
| AQI: 1.05 (AQ_t 0.27 / AQ_t-1 0.26) |
| SGI: 1.43 (Revenue 128.25b / 89.93b) |
| TATA: -0.12 (NI 4.44b - CFO 20.89b) / TA 134.99b) |
| Beneish M-Score: -3.67 (Cap -4..+1) = AAA |
What is the price of ENI shares?
Over the past week, the price has changed by +11.86%, over one month by +28.79%, over three months by +49.28% and over the past year by +78.61%.
Is ENI a buy, sell or hold?
What are the forecasts/targets for the ENI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.4 | -16.9% |
| Analysts Target Price | - | - |
ENI Fundamental Data Overview March 14, 2026
P/E Trailing = 28.6538
P/E Forward = 14.2653
P/S = 0.786
P/B = 1.3353
P/EG = 1.0471
Revenue TTM = 128.25b EUR
EBIT TTM = 8.56b EUR
EBITDA TTM = 15.97b EUR
Long Term Debt = 19.66b EUR (from longTermDebt, last quarter)
Short Term Debt = 6.00b EUR (from shortTermDebt, last quarter)
Debt = 25.66b EUR (Calculated: Short Term 6.00b + Long Term 19.66b)
Net Debt = 20.23b EUR (from netDebt column, last quarter)
Enterprise Value = 82.46b EUR (65.73b + Debt 25.66b - CCE 8.93b)
Interest Coverage Ratio = 1.13 (Ebit TTM 8.56b / Interest Expense TTM 7.56b)
EV/FCF = 21.01x (Enterprise Value 82.46b / FCF TTM 3.92b)
FCF Yield = 4.76% (FCF TTM 3.92b / Enterprise Value 82.46b)
FCF Margin = 3.06% (FCF TTM 3.92b / Revenue TTM 128.25b)
Net Margin = 3.46% (Net Income TTM 4.44b / Revenue TTM 128.25b)
Gross Margin = 32.24% ((Revenue TTM 128.25b - Cost of Revenue TTM 86.90b) / Revenue TTM)
Gross Margin QoQ = 18.27% (prev 39.64%)
Tobins Q-Ratio = 0.61 (Enterprise Value 82.46b / Total Assets 134.99b)
Interest Expense / Debt = 4.48% (Interest Expense 1.15b / Debt 25.66b)
Taxrate = 47.42% (780.0m / 1.65b)
NOPAT = 4.50b (EBIT 8.56b * (1 - 47.42%))
Current Ratio = 1.16 (Total Current Assets 39.48b / Total Current Liabilities 33.91b)
Debt / Equity = 0.52 (Debt 25.66b / totalStockholderEquity, last quarter 49.24b)
Debt / EBITDA = 1.27 (Net Debt 20.23b / EBITDA 15.97b)
Debt / FCF = 5.15 (Net Debt 20.23b / FCF TTM 3.92b)
Total Stockholder Equity = 51.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.24% (Net Income 4.44b / Total Assets 134.99b)
RoE = 8.65% (Net Income TTM 4.44b / Total Stockholder Equity 51.33b)
RoCE = 12.06% (EBIT 8.56b / Capital Employed (Equity 51.33b + L.T.Debt 19.66b))
RoIC = 5.60% (NOPAT 4.50b / Invested Capital 80.44b)
WACC = 5.85% (E(65.73b)/V(91.39b) * Re(7.21%) + D(25.66b)/V(91.39b) * Rd(4.48%) * (1-Tc(0.47)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.60%
[DCF] Terminal Value 84.05% ; FCFF base≈4.36b ; Y1≈3.57b ; Y5≈2.52b
[DCF] Fair Price = 19.40 (EV 77.28b - Net Debt 20.23b = Equity 57.05b / Shares 2.94b; r=5.90% [WACC]; 5y FCF grow -21.96% → 2.90% )
EPS Correlation: -67.27 | EPS CAGR: -20.22% | SUE: 0.65 | # QB: 0
Revenue Correlation: -18.57 | Revenue CAGR: -7.22% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.112 | Chg30d=+0.172 | Revisions Net=+2 | Analysts=4
EPS current Year (2026-12-31): EPS=1.68 | Chg7d=+0.109 | Chg30d=+0.177 | Revisions Net=+8 | Growth EPS=+7.3% | Growth Revenue=+9.5%
EPS next Year (2027-12-31): EPS=1.86 | Chg7d=+0.041 | Chg30d=+0.070 | Revisions Net=+1 | Growth EPS=+10.6% | Growth Revenue=+1.0%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 7.9% - Earnings Yield 3.5%)
[Growth] Growth Spread = +35.1% (Analyst 39.6% - Implied 4.5%)